Challenges of Transitioning to Telehealth During COVID-19
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Health Outcomes in COVID-19 Positive Patients with T1D Using an Insulin Pump
Background and Aims: The use of continuous subcutaneous insulin infusion (CSII) has demonstrated fewer acute complications in patients with type 1…
CGM Usage and Health Outcomes among People with T1D and COVID-19
Background and Aims: Continuous glucose monitoring (CGM) improves glycemic control and reduces complications in patients with type 1 diabetes (T1D). This…
Real-time Continuous Glucose Monitoring (CGM) Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes (T1D)
Background and Aims: The management of type 1 diabetes (T1D) involves strict glucose control to avoid acute complications. The use of…
